Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Two-arm PD and PK Study of Landiolol in Patients with Tachycardic Atrial Fibrillation or Atrial Flutter
2014-001905-42Phase 2Completed
- Sponsor
- AOP Health
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of landiolol in Atrial fibrillation (AFib) and atrial flutter (AFL) (2 arms), sponsored by AOP Health. Started Aug 2014; status: completed.
02
Drugs
landiolol
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on 2014-001905-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001905-42.